載入...
Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application
The discovery that a number of aberrant tumorigenic processes and signal transduction pathways are mediated by druggable protein kinases has led to a revolutionary change in nonsmall cell lung cancer (NSCLC) treatment. Epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) are...
Na minha lista:
| 發表在: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4543855/ https://ncbi.nlm.nih.gov/pubmed/26327924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834015595048 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|